Q: What is Raltegravir used for?

Raltegravir is used to treat HIV-1 infection .

Q: How does Raltegravir work?

Mechanism of Action Raltegravir belongs to a class of drugs known as integrase strand transfer inhibitors (INSTIs). It targets an enzyme called HIV-1 integrase, which is essential for the virus to reproduce. HIV uses this enzyme to insert its own genetic material into the DNA of human immune cells, specifically CD4 cells. By blocking the integrase enzyme, raltegravir prevents the virus from integrating into the host cell's DNA. This interruption stops the virus from making copies of itself, which helps to: Decrease the amount of HIV in the blood (viral load). Increase the number of CD4 cells, which are white blood cells that help the immune system fight infections. While raltegravir helps manage the infection and reduce the risk of complications, it is not a cure for HIV or AIDS. It must be used in combination with other antiretroviral medications to be effective.

Q: What are the brand names for Raltegravir?

Raltegravir is sold under the brand name Isentress .

Q: What are the active ingredients in Raltegravir?

The active ingredient in Raltegravir is raltegravir .

Q: What are the side effects of Raltegravir?

Common side effects of Raltegravir may include: headache nausea fatigue and others Always consult with a healthcare professional about potential side effects.

Q: What drug class is Raltegravir?

Raltegravir belongs to the HIV integrase inhibitor drug class.

Q: Is Raltegravir safe during pregnancy and breastfeeding?

Pregnancy Raltegravir is often prescribed during pregnancy to manage HIV-1 infection and lower the risk of transmitting the virus to the fetus. While research suggests it is generally safe, it should be used only when the benefits outweigh the potential risks. Healthcare providers may encourage enrollment in a pregnancy registry to monitor the health of both the parent and the infant. Breastfeeding The Centers for Disease Control and Prevention (CDC) and other health organizations generally recommend that individuals with HIV avoid breastfeeding. This recommendation is intended to prevent the transmission of HIV to the baby through breast milk. It is currently unknown if raltegravir is excreted in human breast milk, although animal studies have shown the drug can pass into milk. Parents should discuss safe infant feeding alternatives with their healthcare team.

Q: What forms and strengths does Raltegravir come in?

Available Dosage Forms Raltegravir is provided in several different oral forms to accommodate different age groups and dosing requirements: Film-coated tablets: These are standard tablets intended to be swallowed whole. Chewable tablets: These tablets can be chewed or swallowed whole and are often used for pediatric patients. Granules for oral suspension: This form consists of packets of powder that are mixed with water to create a liquid dose, typically used for infants and young children. It is important to note that different formulations of raltegravir are not always interchangeable. For example, the chewable tablets and the oral suspension granules may have different dosing instructions than the standard film-coated tablets. Always use the specific form prescribed by a healthcare provider.

Question 1

What is Raltegravir?

Accepted Answer

Raltegravir is an antiretroviral medication that belongs to a class of drugs known as HIV integrase inhibitors. It is used in combination with other medications to manage human immunodeficiency virus (HIV) infection.

The medication works by blocking integrase, a specific enzyme that the virus needs to multiply and spread throughout the body. By inhibiting this process, the drug helps to reduce the amount of virus present in the blood.

Question 2

What is Raltegravir used for?

Accepted Answer

Raltegravir is used to treat HIV-1 infection.

Question 3

How does Raltegravir work?

Accepted Answer

Mechanism of Action

Raltegravir belongs to a class of drugs known as integrase strand transfer inhibitors (INSTIs). It targets an enzyme called HIV-1 integrase, which is essential for the virus to reproduce. HIV uses this enzyme to insert its own genetic material into the DNA of human immune cells, specifically CD4 cells.

By blocking the integrase enzyme, raltegravir prevents the virus from integrating into the host cell's DNA. This interruption stops the virus from making copies of itself, which helps to:

Decrease the amount of HIV in the blood (viral load).
Increase the number of CD4 cells, which are white blood cells that help the immune system fight infections.

While raltegravir helps manage the infection and reduce the risk of complications, it is not a cure for HIV or AIDS. It must be used in combination with other antiretroviral medications to be effective.

Question 4

What are the brand names for Raltegravir?

Accepted Answer

Raltegravir is sold under the brand name Isentress.

Question 5

What are the active ingredients in Raltegravir?

Accepted Answer

The active ingredient in Raltegravir is raltegravir.

Question 6

What are the side effects of Raltegravir?

Accepted Answer

Common side effects of Raltegravir may include:

headache
nausea
fatigue
and others

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Raltegravir?

Accepted Answer

Raltegravir belongs to the HIV integrase inhibitor drug class.

Question 8

What is the dosage of Raltegravir and how do I take it?

Accepted Answer

Raltegravir is available as regular tablets, chewable tablets, and an oral suspension. It is usually taken once or twice a day. You may take this medication with or without food. It is important to take raltegravir exactly as prescribed and to stay under the care of a healthcare provider during treatment.

Formulation Specifics

Regular tablets: These should be swallowed whole.
Chewable tablets: These may be chewed or swallowed whole.
Oral suspension: This powder must be mixed with water before use. Follow the specific mixing and administration instructions provided with the medication.

Do not switch between different forms of raltegravir (such as regular tablets and chewable tablets) unless directed by a healthcare provider. The different formulations are not interchangeable because they are absorbed by the body differently.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at once to make up for a missed one. It is important not to run out of this medication, as missing doses can affect how well the treatment works.

Question 9

Is Raltegravir safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Raltegravir is often prescribed during pregnancy to manage HIV-1 infection and lower the risk of transmitting the virus to the fetus. While research suggests it is generally safe, it should be used only when the benefits outweigh the potential risks. Healthcare providers may encourage enrollment in a pregnancy registry to monitor the health of both the parent and the infant.

Breastfeeding

The Centers for Disease Control and Prevention (CDC) and other health organizations generally recommend that individuals with HIV avoid breastfeeding. This recommendation is intended to prevent the transmission of HIV to the baby through breast milk. It is currently unknown if raltegravir is excreted in human breast milk, although animal studies have shown the drug can pass into milk. Parents should discuss safe infant feeding alternatives with their healthcare team.

Question 10

What forms and strengths does Raltegravir come in?

Accepted Answer

Available Dosage Forms

Raltegravir is provided in several different oral forms to accommodate different age groups and dosing requirements:

Film-coated tablets: These are standard tablets intended to be swallowed whole.
Chewable tablets: These tablets can be chewed or swallowed whole and are often used for pediatric patients.
Granules for oral suspension: This form consists of packets of powder that are mixed with water to create a liquid dose, typically used for infants and young children.

It is important to note that different formulations of raltegravir are not always interchangeable. For example, the chewable tablets and the oral suspension granules may have different dosing instructions than the standard film-coated tablets. Always use the specific form prescribed by a healthcare provider.

Question 11

What is the FDA approval status of Raltegravir?

Accepted Answer

FDA Approval Status

Raltegravir was first approved by the U.S. Food and Drug Administration (FDA) in 2007. It is classified as an HIV-1 integrase strand transfer inhibitor.

Approved Indications

The medication is indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection. Its approved use extends to:

Adult patients
Pediatric patients weighing at least 2 kg

Regulatory Requirements

The FDA does not require a boxed warning or a Risk Evaluation and Mitigation Strategy (REMS) for raltegravir. However, the drug must be dispensed with an FDA-approved Medication Guide that outlines potential risks, including severe skin reactions and hypersensitivity. Raltegravir is not a controlled substance.

Question 12

What should I know about Raltegravir and cost?

Accepted Answer

Factors Affecting Cost

The price of raltegravir can vary based on several factors:

Formulation: This medication is available in different forms, including film-coated tablets, chewable tablets, and oral suspension. The specific form prescribed can influence the total cost.
Generic vs. Brand Name: Generic raltegravir is available for some strengths and typically costs less than the brand-name version, Isentress.
Insurance and Medicare: Most insurance plans and Medicare Part D cover raltegravir, but the patient's share of the cost depends on the plan's specific benefits and drug tiers.

Financial Assistance Programs

For individuals who have difficulty affording raltegravir, several options may be available:

Manufacturer Assistance: The drug manufacturer may offer copay cards or patient assistance programs for those who qualify based on income or insurance status.
Government Programs: Programs such as the AIDS Drug Assistance Program (ADAP) help provide HIV medications to low-income individuals who are uninsured or underinsured.

Raltegravir

📋Overview

How It Works

Uses

Brand Names

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Raltegravir

Hospitals.net Disclosure